← Leaderboards
Manfred Boehm
Heart, Lung, And Blood Institute
$1,976,433
Attributed
$4,834,148
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2016–24$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,834,148 · 3
By mechanism
U01$4,834,148 · 3
Top collaborators
- Luisa Iruela-Arispe7 shared
- Beth A Kozel4 shared
- Marc S. Williams1 shared
Most similar at Heart, Lung, And Blood Institute
Same institution · by research overlap
- Warren J Leonard$0
- Arshed A Quyyumi$19,415,873
- Han Wen$0
Others in their field
Top investigators on “S Syndrome”
- David Heimbrook · Leidos Biomedical Research, Inc.$365,165,418
- George R Seage · Abt Associates, Inc.$241,364,559
- Barbara Driver · Westat, Inc.$177,853,041
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$174,377,607
- Michelle Vargas · Ppd Development Lp$163,846,102
- Judith S. Currier · University Of California Los Angeles$149,333,820
Research focus
S SyndromeCellsBlood VesselsPhenotypeVascular DiseasesIn VitroEndothelial CellsJob&AposGeneticSmooth Muscle MyocytesSignal TransductionVascular RemodelingPathway InteractionsAffectInduced Pluripotent Stem CellMediatingDisease ModelMutationComplexIn VivoWound HealingMouse ModelCell LineStat3 Gene
Grant awards (61)
Vascular remodeling in patients with rare genetic disorders$2,562,680
ZIA · FY2025 · HL · contact PI
iPS-technology and patient specific disease models$1,537,608
ZIA · FY2025 · HL · contact PI
Murine models of vascular remodeling$1,025,072
ZIA · FY2025 · HL · contact PI
Vascular remodeling in patients with rare genetic disorders$2,072,321
ZIA · FY2024 · HL · contact PI
iPS-technology and patient specific disease models$1,243,393
ZIA · FY2024 · HL · contact PI
Murine models of vascular remodeling$828,928
ZIA · FY2024 · HL · contact PI
Underlying Mechanisms in CADASIL$658,626
U01 · FY2024 · HL
Collaborative Research to Explore Genetic Variation and Phenotypic Spectrum of Elastin and Related Genes$615,941
U01 · FY2024 · HL
Vascular remodeling in patients with rare genetic disorders$1,826,325
ZIA · FY2023 · HL · contact PI
iPS-technology and patient specific disease models$1,095,795
ZIA · FY2023 · HL · contact PI
Murine models of vascular remodeling$730,530
ZIA · FY2023 · HL · contact PI
Underlying Mechanisms in CADASIL$660,986
U01 · FY2023 · HL
Vascular remodeling in patients with rare genetic disorders$1,961,950
ZIA · FY2022 · HL · contact PI
iPS-technology and patient specific disease models$1,156,135
ZIA · FY2022 · HL · contact PI
Murine models of vascular remodeling$805,815
ZIA · FY2022 · HL · contact PI
Underlying Mechanisms in CADASIL$669,256
U01 · FY2022 · HL
Vascular remodeling in patients with rare genetic disorders$1,753,161
ZIA · FY2021 · HL · contact PI
iPS-technology and patient specific disease models$1,051,897
ZIA · FY2021 · HL · contact PI
Murine models of vascular remodeling$701,264
ZIA · FY2021 · HL · contact PI
Underlying Mechanisms in CADASIL$654,979
U01 · FY2021 · HL
Vascular remodeling in patients with rare genetic disorders$1,711,822
ZIA · FY2020 · HL · contact PI
iPS-technology and patient specific disease models$1,027,093
ZIA · FY2020 · HL · contact PI
Murine models of vascular remodeling$684,729
ZIA · FY2020 · HL · contact PI
Vascular remodeling in patients with rare genetic disorders$1,790,284
ZIA · FY2019 · HL · contact PI
iPS-technology and patient specific disease models$1,087,024
ZIA · FY2019 · HL · contact PI
Murine models of vascular remodeling$735,394
ZIA · FY2019 · HL · contact PI
Vascular remodeling in patients with rare genetic disorders$1,632,904
ZIA · FY2018 · HL · contact PI
iPS-technology and patient specific disease models$969,610
ZIA · FY2018 · HL · contact PI
Murine models of vascular remodeling$637,964
ZIA · FY2018 · HL · contact PI
Underlying Mechanisms of Vascular Disease$504,663
U01 · FY2018 · HL
Vascular remodeling in patients with rare genetic disorders$1,413,751
ZIA · FY2017 · HL · contact PI
iPS-technology and patient specific disease models$843,577
ZIA · FY2017 · HL · contact PI
Murine models of vascular remodeling$555,490
ZIA · FY2017 · HL · contact PI
Underlying Mechanisms of Vascular Disease$544,907
U01 · FY2017 · HL
Vascular remodeling in patients with rare genetic disorders$1,258,692
ZIA · FY2016 · HL · contact PI
iPS-technology and patient specific disease models$755,215
ZIA · FY2016 · HL · contact PI
Underlying Mechanisms of Vascular Disease$524,790
U01 · FY2016 · HL
Murine models of vascular remodeling$503,477
ZIA · FY2016 · HL · contact PI
Vascular remodeling in patients with rare genetic disorders$1,067,418
ZIA · FY2015 · HL · contact PI
iPS-technology and patient specific disease models$640,451
ZIA · FY2015 · HL · contact PI
Murine models of vascular remodeling$426,967
ZIA · FY2015 · HL · contact PI
Vascular remodeling in patients with rare genetic disorders$1,086,198
ZIA · FY2014 · HL · contact PI
iPS-technology and patient specific disease models$651,719
ZIA · FY2014 · HL · contact PI
Murine models of vascular remodeling$434,479
ZIA · FY2014 · HL · contact PI
Vascular remodeling in patients with rare genetic disorders$912,408
ZIA · FY2013 · HL · contact PI
iPS-technology and patient specific disease models$690,098
ZIA · FY2013 · HL · contact PI
Murine models of vascular remodeling$690,098
ZIA · FY2013 · HL · contact PI
Murine models of vascular remodeling$804,227
ZIA · FY2012 · HL · contact PI
iPS-technology and patient specific disease models$603,170
ZIA · FY2012 · HL · contact PI
Vascular remodeling in patients with rare genetic disorders$603,170
ZIA · FY2012 · HL · contact PI
Murine models of vascular remodeling$804,763
ZIA · FY2011 · HL · contact PI
Vascular remodeling in patients with rare genetic disorders$603,572
ZIA · FY2011 · HL · contact PI
iPS-technology and patient specific disease models$603,572
ZIA · FY2011 · HL · contact PI
Murine models of vascular remodeling$990,870
ZIA · FY2010 · HL · contact PI
Vascular remodeling in patients with rare genetic disorders$594,522
ZIA · FY2010 · HL · contact PI
iPS-technology and patient specific disease models$396,348
ZIA · FY2010 · HL · contact PI
Stem cell biology in cardiovascular regeneration$2,061,559
ZIA · FY2009 · HL · contact PI
Stem cell biology in cardiovascular regeneration$2,151,181
Z01 · FY2008 · HL · contact PI
Stem cell biology in cardiovascular regeneration$2,412,459
Z01 · FY2007 · HL · contact PI
Stem cell biology in cardiovascular regeneration$0
Z01 · FY2006 · HL · contact PI
Stem cell biology in cardiovascular regeneration$0
Z01 · FY2004 · HL